prorx semaglutide May 18, 2026: FDA warns 503B compounding pharmacy for producing tirzepatide after shortage ended – Partnership for Safe Medicines FDA issues warning about some

Wegovy side effect Wegovy, another medication containing semaglutide, may share common side effects with Ozempic, including nausea and potential gastrointestinal reactions

GLP-1 agonists are not controlled substances, but customs officers may not know this

The glucagon-arm effects (active hepatic fat oxidation, raised resting metabolic rate, cardiac BMR contribution) fade in roughly the same window

Some patients may experience mild side effects, such as nausea, vomiting, diarrhea, or constipation, especially when first starting the treatment

Nausea is the most frequent side effect, affecting roughly 44% of patients as they begin their treatment journey